Status:
COMPLETED
Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
Lead Sponsor:
National University of Malaysia
Collaborating Sponsors:
Malaysia Automotive Robotics and Innovation of Technology Institute
Conditions:
Antibody
Vaccine
Eligibility:
All Genders
18-50 years
Brief Summary
This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.
Detailed Description
Covid -19 infection has been a significant public health burden as it shifted the paradigm of infectious diseases aiming to control the spread and enhance public immune protection. The introduction of...
Eligibility Criteria
Inclusion
- term pregnancies at 37 weeks or more
- vaccinated 2 doses
- in labour
Exclusion
- unvaccinated
- preterm labour less than 37 weeks
- multiple pregnancies
Key Trial Info
Start Date :
July 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2022
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT05305261
Start Date
July 29 2021
End Date
March 18 2022
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UKM Medical Center
Kuala Lumpur, W.Persekutuan, Malaysia, 56000